Clinical Trials Logo

Cushings Disease clinical trials

View clinical trials related to Cushings Disease.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02310269 Completed - Cushings Disease Clinical Trials

Long Term Safety and Efficacy of Pasireotide s.c. in Patients With Cushing's Disease

Start date: March 28, 2013
Phase:
Study type: Observational

This is a non-interventional, multinational, multi-center post-marketing study, to further document the safety and efficacy of pasireotide s.c. administered in routine clinical practice in patients with Cushing's disease. Patients with Cushing's disease and treated with pasireotide s.c. alone and in combination with other therapies will be monitored. For this study, each enrolled patient will be followed up for 3 years after enrollment. Patients who permanently discontinue pasireotide s.c. prior to completing the 3-year observation period will be followed up for 3 months after the last dose of pasireotide s.c.

NCT ID: NCT02180217 Completed - Cushings Disease Clinical Trials

Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease

Start date: October 6, 2014
Phase: Phase 3
Study type: Interventional

The study aimed to confirm long-term efficacy and safety of LCI699 for the treatment of patients with Cushing's disease. It was a pivotal trial which supported the registration of LCI699 for the treatment of patients with Cushing's disease in the US and the EU. This is a phase lll, multi-center, double-blind, randomized withdrawal study of LCI699 following a 24 week, single-arm, open-label dose titration and treatment period which evaluated the safety and efficacy of LCI699 for the treatment of patients with Cushing's disease.

NCT ID: NCT01504399 Completed - Acromegaly Clinical Trials

Rhinological Outcomes in Endonasal Pituitary Surgery

Start date: October 1, 2011
Phase:
Study type: Observational

This is a prospective, multi-center observational study designed to address patient-reported nasal outcomes in adults undergoing endoscopic and microscopic surgical removal of pituitary tumors. The primary objective of this study is to determine the difference in nasal outcomes by using the Anterior Skull Base (ASK) Nasal survey between patients treated with endoscopic surgical technique and those treated with microscopic surgical technique. Patients will be given the ASK Nasal survey to assess their nasal functioning and overall health before their surgery, and at post-operative visits 1-2 weeks, 3 months, and 6 months.

NCT ID: NCT01331239 Completed - Cushing Disease Clinical Trials

Safety and Efficacy of LCI699 in Cushing's Disease Patients

Start date: March 23, 2011
Phase: Phase 2
Study type: Interventional

This exploratory study is a proof of concept study to determine whether LCI699 can safely reduce the level of urinary free cortisol in patients with Cushing's disease. In addition, this study evaluated the long term efficacy and safety of LCI699 including an additional 12 week of treatment followed by a 12 month long term optional extension. A second extension provided patients who were clinically benefitting from LCI699 an opportunity to continue to have access to the drug until LCI699 was commercially available and reimbursed or through the availability of a local access program.